News

“It’s not about the publications or anything else, it’s about making a difference in the lives of people walking through your doors.”

Check out our September, 2022 newsletter as we launch a new seed grant development program, a spotlight on on Dr. Sunil Solomon, and provide more information on our inaugural annual conference!

Philanthropy focuses on projects addressing food and health systems and maternal and child health

The Johns Hopkins Gupta-Klinsky India Institute will award $50,000 to up to three proposed collaborations with India-based partners to address non-communicable diseases and disorders.

By Indu Bhushan and Dr David Peters: The Covid-19 pandemic has exposed weaknesses in every society and health system around the world and continues to disrupt economies globally. Covid-19 seems to be evolving into an endemic disease, much like influenza, that returns regularly and occasionally with large epidemics and pandemics. Additionally, there are always other emerging infectious diseases that remind us to continue strengthening our health systems to prepare against the next health emergency.

To address the global burden of tuberculosis (TB), one of humankind’s oldest scourges, an international collaboration led by Johns Hopkins Medicine has today been awarded up to $200 million in research funding over five years by the U.S. Agency for International Development (USAID) Supporting, Mobilizing and Accelerating Research for Tuberculosis Elimination (SMART4TB) project. “This extraordinary investment from USAID will enable us to have a transformational impact on global efforts to end TB and will provide unparalleled research, strategic development and policy support opportunities for Johns Hopkins Medicine and our collaborators around the world over the next five years,” says SMART4TB consortium chief of party Richard Chaisson, M.D., director of the Center for Tuberculosis Research and professor of medicine at the Johns Hopkins University School of Medicine. “Additionally, we’ll be able to strengthen and empower the people, organizations and communities directly fighting TB in the areas most affected by the disease.”